Paige Mahaney serves as Executive at C4 Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Paige Mahaney has executed 2 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Oct 28, 2025 involved selling 5,644 shares valued at $14.6K.
Paige Mahaney currently holds 99,356 shares of C4 Therapeutics, Inc. (CCCC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Paige Mahaney has been a net neutral trader of CCCC stock. They have purchased $0 and sold $0 worth of shares.
Paige Mahaney's most recent insider trade was on Oct 28, 2025, when they sold 5,644 shares at $2.58 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |